Berberine and yohimbine therapy up-regulates IL-10 expression in septic mice.
Berberine and yohimbine reduce CLP-induced neutrophil tissue infiltration via IL-10.
Berberine and yohimbine attenuate CLP-induced multiple organ damage via IL-10.
Berberine and yohimbine inhibit CLP-induced CCR2 expression in neutrophils via IL-10.